Study on Rapid Immune Modulating Effects
This study is looking at how quickly a special nutritional blend affects your immune cells. We are comparing a "Nutraceutical blend" (made from cow colostrum, mushroom extracts, and vitamin C) with a "Placebo" (four capsules with no active ingredients). The goal is to see if the nutraceutical blend can quickly improve your immune cell surveillance, which is how your body watches for and responds to threats. We'll measure this effect within 3 hours after you take the product. We are looking for 24 healthy adults, aged 18 to 75, who have easily visible veins for blood draws and are willing to follow specific diet and lifestyle routines during the study. The current recruitment status is unclear.
- Study design
- This is a double-blind, placebo-controlled, cross-over study with 24 participants. This means neither you nor the study staff will know if you're receiving the Nutraceutical blend or the Placebo, and you will receive both at different times.
- What's involved
- You will have blood samples taken at baseline, and then 1, 2, and 3 hours after consuming a test product. You will also need to maintain a consistent diet and lifestyle, eat bland breakfasts on clinic visit days, and avoid exercise and certain nutritional items.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your immune cell surveillance will be measured at 3 hours after consuming a test product.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Clinical Trial on Rapid Immune Modulating Effects
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Gitte S. Jensen, PhD · PRINCIPAL_INVESTIGATOR · NIS Labs
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Immune cell surveillance3 hours after consuming a test product for this study protocol
Observation of changes in immune cell trafficking, i.e., the changes in immune cell numbers in the peripheral blood following administration. Data is collected as 'cell numbers per uL whole blood' for the following immune cell types: * Monocytes * NK cells * NKT cells * T cells * non-NK nonT cells